Simple Summary It is easy to find success stories on the internet of patients with cancer who
seem to benefit from using cannabis products. However, scientific substantiation is usually …

The advent of immune checkpoint inhibitors has reinvigorated the field of immuno-oncology.
These monoclonal antibody-based therapies allow the immune system to recognize and …

There is a clear unmet need to improve early colon cancer management. This review
encompasses the current systemic treatment landscape and summarises novel and pivotal trials. …

Purpose To identify the spectrum of patients who undergo disproportionate recurrent computed
tomography (CT) imaging, and to explore the cumulative effects of radiation exposure …

Department of Viroscience, Erasmus MC, Rotterdam, the Netherlandsa; Department of
Medical Microbiology and Infection Prevention, University of Groningen, University Medical …

The mesothelin (MSLN)-targeted 227 Th conjugate is a novel α-therapy developed to treat
MSLN-overexpressing cancers. We radiolabeled the same antibody–chelator conjugate with …

… Johann S de Bono1, Hendrik-Tobias Arkenau2, Eelke H Gort3, Lot A Devriese3, Elisa
Fontana2, Daan G. Knapen4, Crescens Tiu1, Anja Williams2, Derk Jan A de Groot4, Ulug …

OBJECTIVES To compare clinical characteristics, imaging findings and treatment requirements
of patients with immune checkpoint inhibitor-mediated polymyalgia rheumatica (ICI-PMR…

Background Immune checkpoint inhibitors (ICIs) can induce durable responses in multiple
different tumor types. Lymphocyte activation gene-3 (LAG-3) is one of the immune …

Immune checkpoint inhibitors (ICI) have improved outcomes for patients with advanced
cancers, and results in increasing numbers of long-term survivors. For registration studies, …